Aurinia Pharmaceuticals Statistics
Total Valuation
AUPH has a market cap or net worth of $1.21 billion. The enterprise value is $990.72 million.
| Market Cap | 1.21B |
| Enterprise Value | 990.72M |
Important Dates
The next estimated earnings date is Thursday, July 31, 2025, before market open.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AUPH has 135.10 million shares outstanding. The number of shares has increased by 1.68% in one year.
| Current Share Class | 135.10M |
| Shares Outstanding | 135.10M |
| Shares Change (YoY) | +1.68% |
| Shares Change (QoQ) | -3.03% |
| Owned by Insiders (%) | 2.07% |
| Owned by Institutions (%) | 51.48% |
| Float | 131.18M |
Valuation Ratios
The trailing PE ratio is 34.09 and the forward PE ratio is 14.42.
| PE Ratio | 34.09 |
| Forward PE | 14.42 |
| PS Ratio | 5.20 |
| Forward PS | 6.12 |
| PB Ratio | 3.57 |
| P/TBV Ratio | 3.54 |
| P/FCF Ratio | 19.15 |
| P/OCF Ratio | 19.06 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.00, with an EV/FCF ratio of 15.48.
| EV / Earnings | 24.86 |
| EV / Sales | 4.01 |
| EV / EBITDA | 16.00 |
| EV / EBIT | 23.33 |
| EV / FCF | 15.48 |
Financial Position
The company has a current ratio of 5.93, with a Debt / Equity ratio of 0.22.
| Current Ratio | 5.93 |
| Quick Ratio | 5.16 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.24 |
| Debt / FCF | 1.22 |
| Interest Coverage | 9.19 |
Financial Efficiency
Return on equity (ROE) is 11.23% and return on invested capital (ROIC) is 6.06%.
| Return on Equity (ROE) | 11.23% |
| Return on Assets (ROA) | 5.20% |
| Return on Invested Capital (ROIC) | 6.06% |
| Return on Capital Employed (ROCE) | 9.73% |
| Revenue Per Employee | $1.90M |
| Profits Per Employee | $306,500 |
| Employee Count | 130 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 1.16 |
Taxes
In the past 12 months, AUPH has paid $1.96 million in taxes.
| Income Tax | 1.96M |
| Effective Tax Rate | 4.69% |
Stock Price Statistics
The stock price has increased by +56.38% in the last 52 weeks. The beta is 1.17, so AUPH's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +56.38% |
| 50-Day Moving Average | 8.15 |
| 200-Day Moving Average | 8.10 |
| Relative Strength Index (RSI) | 63.57 |
| Average Volume (20 Days) | 2,146,294 |
Short Selling Information
The latest short interest is 10.02 million, so 7.41% of the outstanding shares have been sold short.
| Short Interest | 10.02M |
| Short Previous Month | 10.53M |
| Short % of Shares Out | 7.41% |
| Short % of Float | 7.64% |
| Short Ratio (days to cover) | 8.40 |
Income Statement
In the last 12 months, AUPH had revenue of $247.30 million and earned $39.85 million in profits. Earnings per share was $0.27.
| Revenue | 247.30M |
| Gross Profit | 197.25M |
| Operating Income | 42.47M |
| Pretax Income | -48.10M |
| Net Income | 39.85M |
| EBITDA | 61.92M |
| EBIT | 42.47M |
| Earnings Per Share (EPS) | $0.27 |
Balance Sheet
The company has $312.59 million in cash and $77.91 million in debt, giving a net cash position of $234.68 million or $1.74 per share.
| Cash & Cash Equivalents | 312.59M |
| Total Debt | 77.91M |
| Net Cash | 234.68M |
| Net Cash Per Share | $1.74 |
| Equity (Book Value) | 350.19M |
| Book Value Per Share | 2.54 |
| Working Capital | 337.36M |
Cash Flow
In the last 12 months, operating cash flow was $64.29 million and capital expenditures -$286,000, giving a free cash flow of $64.00 million.
| Operating Cash Flow | 64.29M |
| Capital Expenditures | -286,000 |
| Free Cash Flow | 64.00M |
| FCF Per Share | $0.47 |
Margins
Gross margin is 79.76%, with operating and profit margins of 17.17% and 16.11%.
| Gross Margin | 79.76% |
| Operating Margin | 17.17% |
| Pretax Margin | 16.91% |
| Profit Margin | 16.11% |
| EBITDA Margin | 25.04% |
| EBIT Margin | 17.17% |
| FCF Margin | 25.88% |
Dividends & Yields
AUPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.68% |
| Shareholder Yield | -1.68% |
| Earnings Yield | 3.25% |
| FCF Yield | 5.22% |
Analyst Forecast
The average price target for AUPH is $11.50, which is 28.13% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.50 |
| Price Target Difference | 28.13% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 12.52% |
| EPS Growth Forecast (5Y) | 101.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 23, 2013. It was a reverse split with a ratio of 0.02:1.
| Last Split Date | Oct 23, 2013 |
| Split Type | Reverse |
| Split Ratio | 0.02:1 |
Scores
AUPH has an Altman Z-Score of 2.86 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.86 |
| Piotroski F-Score | 7 |